Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

M.D. Anderson Cancer Center · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
brain-cancercentral-nervous-systemglioblastoma
brain cancer, glioblastoma, cns, central nervous system, malignant brain tumor, recurrent glioblastoma multiforme, gbm, bevacizumab, lomustine, ccnu, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 900248
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.